Partner Headlines - SLXP

  1. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  2. After Big Run, Does Chip Designer NXP Have More Left?

    IBD
  3. S&P 500 Marks New High As Indexes Hold Gains

    IBD
  4. SALIX PHARMACEUTICALS

    IBD
  5. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  6. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  7. Salix Soars On Allergan Buzz

    IBD
  8. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  9. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  10. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  11. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth ...

    Benzinga
  12. Near Entries: Cavium, Autohome, Skyworks And Facebook

    IBD
  13. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  14. Leaders Actavis, Salix Trip Sell Signals

    IBD
  15. Easing Tensions Push Stocks Up In Afternoon Trade

    IBD
  16. Stocks Sharply Higher As Russia Ends Maneuvers

    IBD
  17. Stocks Up Despite Airstrikes; Nvidia, Monster, Ubiquiti Soar

    IBD
  18. Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results

    Benzinga
  19. Sterne Agee Adjusts Estimates For Salix Pharmaceuticals

    Benzinga
  20. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD
  21. Salix misses, guidance in line

    IBD
  22. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  23. Earnings Scheduled For August 7, 2014

    Benzinga
  24. Top Performing Funds Play Favorits

    IBD
  25. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  26. 5 Drug Companies Profiting From Generics

    Benzinga
  27. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  28. TAL Education, Team Health Join The IBD 50 Resistance

    IBD
  29. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  30. Tough Sledding For Growth Stocks Amid Market Distribution

    IBD
  31. US Stock Futures Tumble Ahead Of Morgan Stanley Earnings

    Benzinga
  32. Morning Market Movers

    Benzinga
  33. Benzinga's Top #PreMarket Gainers

    Benzinga
  34. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  35. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  36. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  37. Salix deal underwhelms Street

    IBD
  38. Salix Pharmaceutical's Inversion Deal Makes It Unlikely Merger ...

    Benzinga
  39. Stocks Pick Up After Release Of Fed Minutes

    IBD
  40. FOMC To End QE In October; The Container Store Shares Slide

    Benzinga
  41. Market Awaits Fed Minutes; Facebook Finds Support

    IBD
  42. AeroVironment Surges On Upbeat Results; The Container Store Shares ...

    Benzinga
  43. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  44. Stocks Fade From Higher Open; Lam Hits New High

    IBD
  45. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga
  46. Morning Market Losers

    Benzinga
  47. Traders Sell Salix Pharma Shares Following Merger News

    Benzinga
  48. UPDATE: Salix Pharma Halted Following Release of News Co. Will ...

    Benzinga
  49. IBD 50: Salix, Gilead Among Top Expected EPS Gainers

    IBD
  50. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  51. What Stocks Top Funds Are Buying Now

    IBD
  52. Pharmas Soar To New Highs

    IBD
  53. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  54. S&P 500, Dow At New Highs; 14-Year High For Nasdaq

    IBD
  55. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  56. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD
  57. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  58. Stocks Add To Gains; Salix, Akorn Ramp Higher

    IBD
  59. Mizuho Raises Price Target For Salix Pharmaceuticals

    Benzinga
  60. Salix Pharma's Lead Drug Scores Against Bowel Disease

    IBD
  61. Benzinga's Volume Movers

    Benzinga
  62. Markets Surge; GM June Sales Rise 1%

    Benzinga
  63. Stocks Hitting 52-Week Highs

    Benzinga
  64. Morning Market Movers

    Benzinga
  65. Benzinga's Top #PreMarket Gainers

    Benzinga
  66. Many IBD 50 Stocks Struggle To Climb After Breakouts

    IBD
  67. Benzinga's Top Initiations

    Benzinga
  68. Novo, Other Medicals Display Healthy Action

    IBD
  69. Major Indexes Narrowly Lower As Actavis Rallies

    IBD
  70. Stocks Poised For Soft Start; Micros Systems Surges Premarket

    IBD
  71. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  72. Stocks Hold Slim Gains; Celgene, Salix Rally

    IBD
  73. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  74. Pros And Cons Of Ethical Drug Leader Salix

    IBD
  75. UPDATE: Sterne Agee Reiterates On Salix Pharmaceuticals Ltd. ...

    Benzinga
  76. Stocks Extend Midday Losses As Lululemon, SouFun Tank

    IBD
  77. UPDATE: Sterne Agee Reiterates On Salix Pharmaceuticals Ahead ...

    Benzinga
  78. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  79. More Stock Leaders Emerge From More Industry Groups

    IBD
  80. Selling Accelerates Into Close; Vipshop Rises Pre-Earnings

    IBD
  81. Stocks Open On A Soft Note; Sears, Kate Spade, Coty Jump

    IBD
  82. Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ...

    Benzinga
  83. Valeant EPS Tops, Sales Miss

    IBD
  84. Valeant Reports Mixed Q1 Amid Drug Earnings Bonanza

    IBD
  85. Nasdaq Erases 1% Gain; Priceline Struggles At 200-Day Line

    IBD
  86. Stocks Hold Solid Gains; WhiteWave Surges On Earnings

    IBD
  87. Nasdaq Leads Market Rally But Oil And Gas Producers Lag

    IBD
  88. Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed

    IBD
  89. Modest Losses For Stocks But EOG, Andarko Pace Oil Rally

    IBD
  90. Investing Shortcut Can Get You Up To Speed Quickly

    IBD
  91. Transport, Drug Stocks Act Well Despite Market Woes

    IBD
  92. Forest Acquiring Furiex To Boost GI Franchise

    IBD
  93. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  94. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  95. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  96. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  97. IBD 50: Auto, Other IBD 50 Stocks Forming Bases

    IBD
  98. Stocks Go Red In Heavy Trade; Gap, JPMorgan, NQ Mobile Dive

    IBD
  99. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  100. Ethical Drug Stocks Are Struggling

    IBD
Trading Center